Bill, living with transthyretin amyloidosis, and his wife, Maura ntellia Intellia is Leading the Genome Editing Revolution Corporate Overview MARCH 2022 2 Intellia Therapeutics' Legal Disclaimer This presentation contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs a ...